{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:53:04Z","timestamp":1780455184875,"version":"3.54.1"},"reference-count":29,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nephro.2008.02.002","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T15:46:25Z","timestamp":1212507985000},"page":"281-287","source":"Crossref","is-referenced-by-count":9,"title":["Amylose AA"],"prefix":"10.1684","volume":"4","author":[{"given":"Katia","family":"Stankovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2008.02.002_bib1","series-title":"Reactive amyloidosis and the acute phase response, Bailli\u00e8re's Clinical Rheumatology","first-page":"627","article-title":"The epidemiology of AL and AA amyloidosis","author":"Simms","year":"1994"},{"key":"10.1016\/j.nephro.2008.02.002_bib2","series-title":"Les amyloses","first-page":"377","article-title":"Amylose AA","author":"Hazenberg","year":"2000"},{"key":"10.1016\/j.nephro.2008.02.002_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/95.4.211","article-title":"Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease","volume":"95","author":"Lachmann","year":"2002","journal-title":"Q J Med"},{"key":"10.1016\/j.nephro.2008.02.002_bib4","first-page":"173","article-title":"Amyloidosis and rheumatoid arthritis","volume":"3","author":"Husby","year":"1985","journal-title":"Clin Exp Rheum"},{"key":"10.1016\/j.nephro.2008.02.002_bib5","first-page":"2192","article-title":"An estimate of the prevalence of reactive systemic amyloidosis in ankylosing spondylitis","volume":"22","author":"Escalante","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nephro.2008.02.002_bib6","first-page":"912","article-title":"Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration","volume":"24","author":"Gratacos","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nephro.2008.02.002_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/1529-0131(200101)44:1<66::AID-ANR10>3.0.CO;2-H","article-title":"The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration","volume":"44","author":"Gomez-Casanovas","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2008.02.002_bib8","first-page":"1482","article-title":"Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis","volume":"33","author":"Uda","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nephro.2008.02.002_bib9","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.humpath.2007.04.013","article-title":"Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response","volume":"38","author":"Verine","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nephro.2008.02.002_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ndt\/7.9.908","article-title":"Outcome of patients with secondary amyloidosis in dialysis treatment","volume":"7","author":"Ylinen","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2008.02.002_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13506129509031897","article-title":"Amyloid goiter: report of the clinical, histological and biochemical features of five cases","volume":"2","author":"Gal","year":"1995","journal-title":"Amyloid"},{"key":"10.1016\/j.nephro.2008.02.002_bib12","first-page":"915","article-title":"Adrenal dysfunction in patients with renal amyloid","volume":"76","author":"Danby","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.nephro.2008.02.002_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/art.1780360518","article-title":"Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis: a prospective clinical and immunohistologic study in 59 patients","volume":"36","author":"Hachulla","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2008.02.002_bib14","doi-asserted-by":"crossref","unstructured":"Grateau G, J\u00e9ru I, Rouaghe S, Cazeneuve C, Ravet N, Duquesnoy P, et al. Amyloidosis and auto-inflammatory syndromes. In: Kostanpopoulos K, editor. Inflammation and auto-inflammation. Pathophysiology and molecular aspects. Curr Drug Target Inflamm Allergy 2005;4(Special Issue):57\u201365.","DOI":"10.2174\/1568010053622786"},{"key":"10.1016\/j.nephro.2008.02.002_bib15","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.02.002_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/13506129809007299","article-title":"SAA1 alleles as risk factors in reactive systemic AA amyloidosis","volume":"5","author":"Booth","year":"1998","journal-title":"Amyloid"},{"key":"10.1016\/j.nephro.2008.02.002_bib17","first-page":"1136","article-title":"Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever","volume":"67","author":"Cazeneuve","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nephro.2008.02.002_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/art.10944","article-title":"The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever","volume":"48","author":"Gershoni-Baruch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2008.02.002_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13506120308995250","article-title":"An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians","volume":"10","author":"Yamada","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.nephro.2008.02.002_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine\u00ae in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.02.002_bib21","first-page":"509","article-title":"Role of A-SAA in monitoring subclinical inflammation and in Colchicine\u00ae dosage in familial Mediterranean fever","volume":"21","author":"Duzova","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nephro.2008.02.002_bib22","first-page":"1201","article-title":"Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis","volume":"20","author":"Savolainen","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nephro.2008.02.002_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/41.7.833","article-title":"Treatment of AA amyloid with chlorambucil","volume":"41","author":"Ortiz-Santamaria","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.nephro.2008.02.002_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/40.7.821","article-title":"Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide","volume":"40","author":"Chevrel","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.nephro.2008.02.002_bib25","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2008.02.002_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjmed.2005.01.028","article-title":"Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists","volume":"118","author":"Fernandez-Nebro","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2008.02.002_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0295-143","article-title":"Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease","volume":"1","author":"Kisilevsky","year":"1995","journal-title":"Nature Med"},{"key":"10.1016\/j.nephro.2008.02.002_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nephro.2008.02.002_bib29","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.02470607","article-title":"Presentation and Outcome of Patients with Systemic Amyloidosis Undergoing Dialysis","author":"Boll\u00e9e","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972550800045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972550800045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2008.02.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:01:38Z","timestamp":1741183298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972550800045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S176972550800045X"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2008.02.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}